Thyroid hormone receptors in health and disease

Minerva Endocrinologica

Volumn 37, Issue 4, 2012, Pages 291-303

  Boelen, A ^a   Kwakkel, J ^a   Fliers, E ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Homeostasis; Receptors, thyroid hormone; Thyroid hormones

Indexed keywords

THYROID HORMONE; THYROID HORMONE RECEPTOR;

GENE; GENE MUTATION; GENOMICS; HUMAN; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; NONHUMAN; NONTHYROIDAL ILLNESS SYNDROME; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; SYNDROME; THRA GENE; THRB GENE;

ANIMALS; DIMERIZATION; ENERGY METABOLISM; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; HYPERTHYROIDISM; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHYROIDISM; IODIDE PEROXIDASE; MICE; MICE, KNOCKOUT; MUTATION; ORGAN SPECIFICITY; RECEPTORS, THYROID HORMONE; RETINOID X RECEPTORS; RNA, MESSENGER; THYROID GLAND; THYROID HORMONES; THYROTROPIN; THYROTROPIN-RELEASING HORMONE;

EID: 84875309220     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. Maia AL, Kim BW, Huang SA, Harney JW, Larsen PR. Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest 2005;115:2524-33. (Pubitemid 41266215)
2. Chanoine JP, Braverman LE, Farwell AP, Safran M, Alex S, Dubord S et al. The thyroid gland is a major source of circulating T3 in the rat. J Clin Invest 1993;91:2709-13. (Pubitemid 23182526)
3. Heuer H, Visser TJ. Minireview: Pathophysiological importance of thyroid hormone transporters. Endocrinology 2009;150:1078-83.
4. Yen PM, Ando S, Feng X, Liu Y, Maruvada P, Xia X. Thyroid hormone action at the cellular, genomic and target gene levels. Mol Cell Endocrinol 2006;246:121-7. (Pubitemid 43238405)
5. Kohrle J. The selenoenzyme family of deiodinase isozymes controls local thyroid hormone availability. Rev Endocr Metab Disord 2000;1:49-58.
6. Schneider MJ, Fiering SN, Thai B, Wu SY, St Germain E, Parlow AF et al. Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice. Endocrinology 2006;147:580-9. (Pubitemid 43008392)
7. Jakobs TC, Schmutzler C, Meissner J, Kohrle J. The promoter of the human type I 5′-deiodinase gene-mapping of the transcription start site and identification of a DR+4 thyroid-hormone-responsive element. Eur J Biochem 1997;247:288-97. (Pubitemid 27319516)
8. Toyoda N, Zavacki AM, Maia AL, Harney JW, Larsen PR. A novel retinoid X receptor-independent thyroid hormone response element is present in the human type 1 deiodinase gene. Mol Cell Biol 1995;15:5100-12.
9. Gereben B, Zeold A, Dentice M, Salvatore D, Bianco AC. Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences. Cell Mol Life Sci 2008;65:570-90.
10. Burmeister LA, Pachucki J, St Germain DL. Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and posttranslational mechanisms. Endocrinology 1997;138:5231-7. (Pubitemid 27509683)
11. Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev 2001;81:1269-304. (Pubitemid 32606670)
12. Bassett JH, Harvey CB, Williams GR. Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol 2003;213:1-11. (Pubitemid 38229150)
13. Liu RT, Suzuki S, Miyamoto T, Takeda T, Ozata M, DeGroot LJ. The dominant negative effect of thyroid hormone receptor splicing variant alpha 2 does not require binding to a thyroid response element. Mol Endocrinol 1995;9:86-95.
14. Chassande O, Fraichard A, Gauthier K, Flamant F, Legrand C, Savatier P et al. Identification of transcripts initiated from an internal promoter in the c-erbA alpha locus that encode inhibitors of retinoic acid receptor-alpha and triiodothyronine receptor activities. Mol Endocrinol 1997;11:1278-90. (Pubitemid 28041335)
15. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev 2001;81:1097-142. (Pubitemid 32606667)
16. Wrutniak-Cabello C, Casas F, Cabello G. Thyroid hormone action in mitochondria. J Mol Endocrinol 2001;26:67-77. (Pubitemid 32125122)
17. Wood WM, Dowding JM, Haugen BR, Bright TM, Gordon DF, Ridgway EC. Structural and functional characterization of the genomic locus encoding the murine beta 2 thyroid hormone receptor. Mol Endocrinol 1994;8:1605-17.
18. Williams GR. Cloning and characterization of two novel thyroid hormone receptor beta isoforms. Mol Cell Biol 2000;20:8329-42.
19. Harvey CB, Bassett JH, Maruvada P, Yen PM, Williams GR. The rat thyroid hormone receptor (TR) Deltabeta3 displays cell-, TR isoform-, and thyroid hormone response element-specific actions. Endocrinology 2007;148:1764-73. (Pubitemid 46457139)
20. Stoykov I, Zandieh-Doulabi B, Moorman AF, Christoffels V, Wiersinga WM, Bakker O. Expression pattern and ontogenesis of thyroid hormone receptor isoforms in the mouse heart. J Endocrinol 2006;189:231-45.
21. Alkemade A, Friesema EC, Unmehopa UA, Fabriek BO, Kuiper GG, Leonard JL et al. Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus. J Clin Endocrinol Metab 2005;90:4322-34. (Pubitemid 41058215)
22. Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 2000;14:121-41. (Pubitemid 30070977)
23. Ortiga-Carvalho TM, Shibusawa N, Nikrodhanond A, Oliveira KJ, Machado DS, Liao XH et al. Negative regulation by thyroid hormone receptor requires an intact coactivator-binding surface. J Clin Invest 2005;115:2517-23. (Pubitemid 41266214)
24. Davis PJ, Davis FB, Lin HY, Mousa SA, Zhou M, Luidens MK. Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor. Am J Physiol Endocrinol Metab 2009;297:E1238-E1246.
25. Goglia F, Lanni A, Barth J, Kadenbach B. Interaction of diiodothyronines with isolated cytochrome c oxidase. FEBS Lett 1994;346:295-8. (Pubitemid 24185622)
26. Lin HY, Sun M, Tang HY, Lin C, Luidens MK, Mousa SA et al. L-Thyroxine vs. 3,5,3′-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Am J Physiol Cell Physiol 2009;296:C980-C991.
27. Davis PJ, Leonard JL, Davis FB. Mechanisms of nongenomic actions of thyroid hormone. Front Neuroendocrinol 2008;29:211-8. (Pubitemid 351467119)
28. Guigon CJ, Cheng SY. Novel non-genomic signaling of thyroid hormone receptors in thyroid carcinogenesis. Mol Cell Endocrinol 2009;308:63-9.
29. Refetoff S, Dumitrescu AM. Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract Res Clin Endocrinol Metab 2007;21:277-305. (Pubitemid 46888195)
30. Ferrara AM, Onigata K, Ercan O, Woodhead H, Weiss RE, Refetoff S. Homozygous thyroid hormone receptor beta-gene mutations in resistance to thyroid hormone: three new cases and review of the literature. J Clin Endocrinol Metab 2012;97:1328-36.
31. Lazar MA. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev 1993;14:184-93. (Pubitemid 23118416)
32. Bochukova E, Schoenmakers N, Agostini M, Schoenmakers E, Rajanayagam O, Keogh JM et al. A mutation in the thyroid hormone receptor alpha gene. N Engl J Med 2012;366:243-9.
33. van Mullem A., van Heerebeek R., Chrysis D, Visser E, Medici M, Andrikoula M et al. Clinical phenotype and mutant TRalpha1. N Engl J Med 2012;366:1451-3.
34. Gauthier K, Chassande O, Plateroti M, Roux JP, Legrand C, Pain B et al. Different functions for the thyroid hormone receptors TRalpha and TRbeta in the control of thyroid hormone production and postnatal development. EMBO J 1999;18:623-31. (Pubitemid 29057247)
35. Forrest D, Hanebuth E, Smeyne RJ, Everds N, Stewart CL, Wehner JM et al. Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor beta: evidence for tissue-specific modulation of receptor function. EMBO J 1996;15:3006-15. (Pubitemid 26187749)
36. Weiss RE, Murata Y, Cua K, Hayashi Y, Seo H, Refetoff S. Thyroid hormone action on liver, heart, and energy expenditure in thyroid hormone receptor beta-deficient mice. Endocrinology 1998;139:4945-52. (Pubitemid 28533441)
37. Gauthier K, Plateroti M, Harvey CB, Williams GR, Weiss RE, Refetoff S et al. Genetic analysis reveals different functions for the products of the thyroid hormone receptor alpha locus. Mol Cell Biol 2001;21:4748-60. (Pubitemid 32588255)
38. Nikrodhanond AA, Ortiga-Carvalho TM, Shibusawa N, Hashimoto K, Liao XH, Refetoff S et al. Dominant role of thyrotropin-releasing hormone in the hypothalamic-pituitary-thyroid axis. J Biol Chem 2006;281:5000-5007 (Pubitemid 43847763)
39. Fraichard A, Chassande O, Plateroti M, Roux JP, Trouillas J, Dehay C et al. The T3R alpha gene encoding a thyroid hormone receptor is essential for postnatal development and thyroid hormone production. EMBO J 1997;16:4412-4420 (Pubitemid 27298194)
40. Plateroti M, Gauthier K, Domon-Dell C, Freund JN, Samarut J, Chassande O. Functional interference between thyroid hormone receptor alpha (TRalpha) and natural truncated TRDeltaalpha isoforms in the control of intestine development. Mol Cell Biol 2001;21:4761-72. (Pubitemid 32588256)
41. Macchia PE, Takeuchi Y, Kawai T, Cua K, Gauthier K, Chassande O et al. Increased sensitivity to thyroid hormone in mice with complete deficiency of thyroid hormone receptor alpha. Proc Natl Acad Sci U S A 2001;8:349-54. (Pubitemid 32095912)
42. Pelletier P, Gauthier K, Sideleva O, Samarut J, Silva JE. Mice lacking the thyroid hormone receptor-alpha gene spend more energy in thermogenesis, burn more fat, and are less sensitive to high-fat diet-induced obesity. Endocrinology 2008;149:6471-86.
43. Wikstrom L, Johansson C, Salto C, Barlow C, Campos BA, Baas F et al. Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1. EMBO J 1998;17:455-61. (Pubitemid 28045486)
44. Salto C, Kindblom JM, Johansson C, Wang Z, Gullberg H, Nordstrom K et al. Ablation of TRalpha2 and a concomitant overexpression of alpha1 yields a mixed. Mol Endocrinol 2001;15:2115-28.
45. Gothe S, Wang Z, Ng L, Kindblom JM, Barros AC, Ohlsson C et al. Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev 1999;13:1329-41. (Pubitemid 29250200)
46. Tinnikov A, Nordstrom K, Thoren P, Kindblom JM, Malin S, Rozell B et al. Retardation of post-natal development caused by a negatively acting thyroid hormone receptor alpha1. EMBO J 2002;21:5079-87.
47. Kaneshige M, Suzuki H, Kaneshige K, Cheng J, Wimbrow H, Barlow C et al. A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice. Proc Natl Acad Sci U S A 2001;98:15095-100. (Pubitemid 34013975)
48. Liu YY, Schultz JJ, Brent GA. A thyroid hormone receptor alpha gene mutation (P398H) is associated with visceral adiposity and impaired catecholamine-stimulated lipolysis in mice. J Biol Chem 2003;278:38913-20. (Pubitemid 37221791)
49. Flamant F, Poguet AL, Plateroti M, Chassande O, Gauthier K, Streichenberger N et al. Congenital Hypothyroid Pax8(-/-) Mutant Mice Can Be Rescued by Inactivating the TRalpha Gene. Mol Endocrinol 2002;16:24-32. (Pubitemid 34044495)
50. Docter R, Krenning EP, de Jong M, Hennemann G. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol (Oxf) 1993;39:499-518. (Pubitemid 23323946)
51. Boelen A, Wiersinga WM, Kohrle J. Contributions of cytokines to nonthyroidal illness. Curr Opin Endocrinol Diabetes. 2006;13:444-50. (Pubitemid 44342171)
52. Boelen A, Kwakkel J, Fliers E. Beyond low plasma T3: local thyroid hormone metabolism during inflammation and infection. Endocr Rev 2011;32:670-93.
53. Lazar MA. Sodium butyrate selectively alters thyroid hormone receptor gene expression in GH3 cells. J Biol Chem 1990;265:17474-7.
54. Kwakkel J, Wiersinga WM, Boelen A. Differential involvement of nuclear factor-kappaB and activator protein-1 pathways in the interleukin-1beta-mediated decrease of deiodinase type 1 and thyroid hormone receptor beta1 mRNA. J Endocrinol 2006;189:37-44. (Pubitemid 43670699)
55. Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. Sick euthyroid syndrome is associated with decreased TR expression and DNA binding in mouse liver. Am J Physiol Endocrinol Metab 2003;284.E228-E236. (Pubitemid 36076241)
56. Koenig RJ, Lazar MA, Hodin RA, Brent GA, Larsen PR, Chin WW et al. Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing. Nature 1989;337:659-61. (Pubitemid 19054295)
57. Thijssen-Timmer DC, Peeters RP, Wouters P, Weekers F, Visser TJ, Fliers E et al. Thyroid hormone receptor isoform expression in livers of critically ill patients. Thyroid 2007;17:105-12. (Pubitemid 46365564)
58. Chamba A, Neuberger J, Strain A, Hopkins J, Sheppard MC, Franklyn JA. Expression and function of thyroid hormone receptor variants in normal and chronically diseased human liver. J Clin Endocrinol Metab 1996;81:360-7. (Pubitemid 26035046)
59. Malik IA, Baumgartner BG, Naz N, Sheikh N, Moriconi F, Ramadori G. Changes in gene expression of DOR and other thyroid hormone receptors in rat liver during acute-phase response. Cell Tissue Res 2010;342:261-72.
60. Yu F, Gothe S, Wikstrom L, Forrest D, Vennstrom B, Larsson L. Effects of thyroid hormone receptor gene disruption on myosin isoform expression in mouse skeletal muscles. Am J Physiol Regul Integr Comp Physiol 2000;278:R1545-R1554. (Pubitemid 30439276)
61. Simonides WS, van Hardeveld C. Thyroid hormone as a determinant of metabolic and contractile phenotype of skeletal muscle. Thyroid 2008;18:205-16 (Pubitemid 351271533)
62. Harper ME, Seifert EL. Thyroid hormone effects on mitochondrial energetics. Thyroid 2008;18:145-56 (Pubitemid 351271528)
63. Moreno M, de Lange P, Lombardi A, Silvestri E, Lanni A, Goglia F. Metabolic effects of thyroid hormone derivatives. Thyroid 2008;18:239-53. (Pubitemid 351271526)
64. Fredriksson K, Hammarqvist F, Strigard K, Hultenby K, Ljungqvist O, Wernerman J et al. Derangements in mitochondrial metabolism in intercostal and leg muscle of critically ill patients with sepsis-induced multiple organ failure. Am J Physiol Endocrinol Metab 2006;291:E1044-E1050.
65. Zang Q, Maass DL, Tsai SJ, Horton JW. Cardiac mitochondrial damage and inflammation responses in sepsis. Surg Infect (Larchmt) 2007;8:41-54 (Pubitemid 46598294)
66. Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA, Pronovost PJ, Needham DM. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med 2007;33:1876-91. (Pubitemid 47632264)
67. Kwakkel J, Chassande O, van Beeren HC, Fliers E, Wiersinga WM, Boelen A. Thyroid hormone receptor {alpha} modulates lipopolysaccharide-induced changes in peripheral thyroid hormone metabolism. Endocrinology 2010;151:1959-69.
68. Feingold KR, Moser A, Patzek SM, Shigenaga JK, Grunfeld C. Infection decreases fatty acid oxidation and nuclear hormone receptors in the diaphragm. J Lipid Res 2009;50:2055-63.
69. Lado-Abeal J, Romero A, Castro-Piedras I, Rodriguez-Perez A, varez-Escudero J. Thyroid hormone receptors are down-regulated in skeletal muscle of patients with non-thyroidal illness syndrome secondary to non-septic shock. Eur J Endocrinol 2010;163:765-73.
70. Lu B, Moser AH, Shigenaga JK, Feingold KR, Grunfeld C. Type II nuclear hormone receptors, coactivator, and target gene repression in adipose tissue in the acute-phase response. J Lipid Res 2006;47:2179-90. (Pubitemid 44936128)
71. Rodriguez-Perez A, Palos-Paz F, Kaptein E, Visser TJ, Dominguez-Gerpe L, varez-Escudero J et al. Identification of molecular mechanisms related to nonthyroidal illness syndrome in skeletal muscle and adipose tissue from patients with septic shock. Clin Endocrinol (Oxf) 2008;68:821-7. (Pubitemid 351533438)
72. Amma LL, Campos-Barros A, Wang Z, Vennstrom B, Forrest D. Distinct tissue-specific roles for thyroid hormone receptors beta and alpha1 in regulation of type 1 deiodinase expression. Mol Endocrinol 2001;15:467-75. (Pubitemid 32221922)
73. Kwakkel J, Wiersinga WM, Boelen A. Interleukin-1beta modulates endogenous thyroid hormone receptor alpha gene transcription in liver cells. J Endocrinol 2007;194:257-65. (Pubitemid 47249664)
74. Kwakkel J, van Beeren HC, Ackermans MT, Platvoetter Schiphorst MC, Fliers E, Wiersinga WM et al. Skeletal muscle deiodinase type 2 regulation during illness in mice. J Endocrinol 2009;203:263-70.
75. Xu B, Koenig RJ. Regulation of thyroid hormone receptor alpha2 RNA binding and subcellular localization by phosphorylation. Mol Cell Endocrinol 2005;245:147-57. (Pubitemid 43049756)
76. Chen SL, Chang YJ, Wu YH, Lin KH. Mitogen-activated protein kinases potentiate thyroid hormone receptor transcriptional activity by stabilizing its protein. Endocrinology 2003;144:1407-19. (Pubitemid 36428483)
77. Wolf M, Hansen N, Greten H. Interleukin 1 beta, tumor necrosis factor-alpha and interleukin 6 decrease nuclear thyroid hormone receptor capacity in a liver cell line. Eur J Endocrinol 1994;131:307-12.
78. Schug JaOGC. TESS: Transcription element search software on the WWW. Technical Report CBIL-TR-1997-1001-v0.0. 8 ed. Pennsylvania: Computational Biology and Informatic Laboratory, School of Medicine University of Pennsylvania 1998;1-10.
79. Nagaya T, Fujieda M, Otsuka G, Yang JP, Okamoto T, Seo H. A potential role of activated NF-kappa B in the pathogenesis of euthyroid sick syndrome. J Clin Invest 2000;106:393-402. (Pubitemid 30655639)
80. Yu J, Koenig RJ. Regulation of hepatocyte thyroxine 5′-deiodinase by T3 and nuclear receptor coactivators as a model of the sick euthyroid syndrome. J Biol Chem 2000;275:38296-301. (Pubitemid 32009151)
81. Yu J, Koenig RJ. Induction of type 1 iodothyronine deiodinase to prevent the nonthyroidal illness syndrome in mice. Endocrinology 2006;147:3580-5. (Pubitemid 43901150)
82. Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. The acute phase response is associated with retinoid X receptor repression in rodent liver. J Biol Chem 2000;275:16390-9. (Pubitemid 30366957)
83. Fliers E, Alkemade A, Wiersinga WM, Swaab DF. Hypothalamic thyroid hormone feedback in health and disease. Prog Brain Res 2006;153:189-207. (Pubitemid 44107416)
84. Forrest D, Reh TA, Rusch A. Neurodevelopmental control by thyroid hormone receptors. Curr Opin Neurobiol 2002;12:49-56. (Pubitemid 34175274)
85. Mebis L, Debaveye Y, Ellger B, Derde S, Ververs EJ, Langouche L et al. Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illness. Crit Care 2009;13;R147
86. Boelen A, Kwakkel J, Thijssen-Timmer DC, Alkemade A, Fliers E, Wiersinga WM. Simultaneous changes in central and peripheral components of the hypothalamus-pituitary-thyroid axis in lipopolysaccharide-induced acute illness in mice. J Endocrinol 2004;182:315-23 (Pubitemid 39199015)
87. Shupnik MA. Thyroid hormone suppression of pituitary hormone gene expression. Rev Endocr Metab Disord 2000;1:35-42.
88. Delhase M, Castrillo JL, de la Hoya M, Rajas F, Hooghe-Peters EL. AP-1 and Oct-1 transcription factors down-regulate the expression of the human PIT1/GHF1 gene. J Biol Chem 1996;271:32349-32358 (Pubitemid 26422276)
89. Boelen A, Kwakkel J, Chassande O, Fliers E. Thyroid Hormone Receptor beta mediates acute illness-induced alterations in central thyroid hormone metabolism. J Neuroendocrinol 2009;21:465-72.
90. Fekete C, Lechan RM. Negative feedback regulation of hypophysiotropic thyrotropin-releasing hormone (TRH) synthesizing neurons: role of neuronal afferents and type 2 deiodinase. Front Neuroendocrinol 2007;28:97-114. (Pubitemid 47033939)
91. Kwakkel J, Chassande O, van Beeren HC, Wiersinga WM, Boelen A. Lacking thyroid hormone receptor beta gene does not influence alterations in peripheral thyroid hormone metabolism during acute illness. J Endocrinol 2008;197:151-8. (Pubitemid 351566934)
92. Shibusawa N, Hollenberg AN, Wondisford FE. Thyroid hormone receptor DNA binding is required for both positive and negative gene regulation. J Biol Chem 2003;278:732-8. (Pubitemid 36790743)
93. Abel ED, Boers ME, Pazos-Moura C, Moura E, Kaulbach H, Zakaria M et al. Divergent roles for thyroid hormone receptor beta isoforms in the endocrine axis and auditory system. J Clin Invest 1999;104:291-300.